|
gptkbp:instanceOf
|
biotechnology company
|
|
gptkbp:acquisition
|
gptkb:BioGen_Innovations
|
|
gptkbp:awards
|
Best_Biotech_Company_2022
|
|
gptkbp:CEO
|
gptkb:Jane_Doe
|
|
gptkbp:clinicalTrials
|
ongoing
completed
|
|
gptkbp:collaborations
|
gptkb:Stanford_University
gptkb:University_of_California
|
|
gptkbp:community_engagement
|
educational programs
health fairs
|
|
gptkbp:customerBase
|
hospitals
pharmaceutical companies
research institutions
|
|
gptkbp:employees
|
500
|
|
gptkbp:founded
|
1990
|
|
gptkbp:founder
|
gptkb:Dr._John_Smith
|
|
gptkbp:funding
|
government grants
Series C funding
|
|
gptkbp:future_plans
|
develop new therapies
expand into new markets
increase R&D investment
|
|
gptkbp:headquarters
|
gptkb:San_Francisco,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GeneTech
|
|
gptkbp:impact
|
improved patient outcomes
advancements in genetic research
increased access to genetic testing
|
|
gptkbp:industry
|
Biotechnology
|
|
gptkbp:investmentFocus
|
Venture_Capital_Partners
|
|
gptkbp:location
|
gptkb:Asia
gptkb:North_America
Europe
|
|
gptkbp:market
|
global
|
|
gptkbp:mission
|
advancing genetic research
|
|
gptkbp:partnerships
|
gptkb:World_Health_Organization
gptkb:National_Institutes_of_Health
gptkb:HealthCorp
Global Health Initiative
|
|
gptkbp:patentCitation
|
over 100
|
|
gptkbp:products
|
genetic testing services
gene therapy solutions
|
|
gptkbp:regulatoryCompliance
|
FDA_approved
ISO_certified
|
|
gptkbp:research_focus
|
personalized medicine
CRISPR technology
|
|
gptkbp:revenue
|
$200 million
|
|
gptkbp:social_responsibility
|
community health initiatives
environmental sustainability
|
|
gptkbp:subsidiary
|
gptkb:GeneTech_Diagnostics
gptkb:GeneTech_Therapeutics
|
|
gptkbp:sustainability_initiatives
|
renewable energy use
waste reduction programs
|
|
gptkbp:technology
|
bioinformatics
synthetic biology
genome sequencing
|
|
gptkbp:vision
|
improving human health
|
|
gptkbp:website
|
www.genetech.com
|